Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,170,643
+$314,123 QoQ
Shares Held
976
+22.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#2,989
of 4,605 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vantus Wealth LLC holds $6,712,710 across 11 Drug Manufacturers - General names. LLY ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,974 | $1,251,656 | |
| 2 | JNJ |
Johnson & Johnson
|
4,860 | $1,234,293 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
976 | $1,170,643 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,250 | $674,625 | |
| 5 | PFE |
Pfizer Inc
|
22,727 | $547,265 | |
| 6 | AMGN |
Amgen Inc
|
1,262 | $456,995 | |
| 7 | AZN |
Astrazeneca PLC
|
2,032 | $385,307 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,852 | $360,321 |
All Filings in LLY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,170,643 | 976 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $856,520 | 797 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||